The federal health department's recent 409-page report on pediatric gender dysphoria promotes therapy as a preferred approach over medical treatment like hormones or surgery. It claims that while there are sparse reports of harms from medical treatments, they should still be avoided due to potential irreversible consequences. The review is juxtaposed against the guidance from major medical associations urging support for transgender healthcare, highlighting a tension between scientific views and activist perspectives. The report, responding to a presidential executive order, emphasizes caution in interpreting existing studies due to limitations in harm detection and lacks recommendations for adult care.
Evidence for harms associated with pediatric medical transition in systematic reviews is sparse, but this finding should be interpreted with caution, the report states.
Our duty is to protect our nation's children, not expose them to unproven and irreversible medical interventions, said Dr Jay Bhattacharya, NIH director.
Collection
[
|
...
]